Period Ending | Dec 31, 2009 | Dec 31, 2008 |
Total Revenue
|
2,826,500
|
2,882,400
| Cost of Revenue | 974,700 | 1,079,800 | |
Gross Profit
|
1,851,800
|
1,802,600
| |
|
Operating Expenses |
|
Research Development | 71,900 | 72,800 |
|
Selling General and Administrative | 1,100,300 | 1,021,000 |
|
Non Recurring |
-
| 13,100 |
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
679,600
|
695,700
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
|
Earnings Before Interest And Taxes | 587,000 | 695,700 |
|
Interest Expense |
-
| 43,300 |
|
Income Before Tax | 587,000 | 652,400 |
|
Income Tax Expense | 176,400 | 251,400 |
|
Minority Interest | (11,000) | (7,100) |
|
|
|
Net Income From Continuing Ops | 399,600 | 393,900 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
399,600
|
393,900
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
$399,600
|
$393,900
|
|